SEI Investments’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

SEI Investments’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-26,816	Closed	-$334K	–	3226
2016 Q4	$334K	Sell	26,816 -16,115	-38%	-$194K	﹤0.01%	1672
2016 Q3	$588K	Sell	42,931 -15,010	-26%	-$151K	﹤0.01%	1415
2016 Q2	$428K	Buy	57,941 +25,310	+78%	+$190K	﹤0.01%	1391
2016 Q1	$208K	Buy	32,631 +32,559	+45,221%	+$182K	﹤0.01%	1515
2015 Q4	$0	Sell	72 -23,587	-100%	-$155K	﹤0.01%	2837
2015 Q3	$138K	Buy	23,659 +199	+0.8%	+$1.53K	﹤0.01%	1698
2015 Q2	$194K	Sell	23,460 -640	-3%	-$5.66K	﹤0.01%	1389
2015 Q1	$199K	Sell	24,100 -2,340	-9%	-$17.3K	﹤0.01%	1412
2014 Q4	$182K	Buy	+26,440	New	+$165K	﹤0.01%	1441

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

SEI Investments's ARIA Position: Q1 2017 in Review

SEI Investments sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 26,816 shares — an estimated $334K sold.

SEI Investments first reported a position in ARIA in Q4 2014 and held it in 9 quarters. The position peaked at $588K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

SEI Investments reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
SEI Investments sold 26,816 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $334K.
SEI Investments first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 9 quarters.
SEI Investments's Ariad Pharmaceuticals Inc position peaked at $588K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on SEI Investments's 13F filing for Q1 2017, filed 5 May 2017.